Equities
FocalTherics launches public offering of ADSs
Biotech firm FocalTherics plans to raise capital through a public offering of American Depositary Shares, with proceeds to support operations and growth initiatives.
Genuine Parts raises quarterly dividend to $1.0625 per share
Automotive and industrial parts distributor increases payout for Q2, marking 70 years of consecutive dividend growth.
FocalTherics Q2 HIFU revenue rises 34-39% amid medical device growth
Medical device maker FocalTherics reports strong quarterly growth in its high-intensity focused ultrasound segment, driven by rising demand for precision treatment tools.
Elemental Royalty posts record Q2 operating cash flow
Cash flow surged to a new high, reflecting strong operational performance in the royalty sector.
Amazon reinstates binding arbitration, blocks class-action suits
Retail giant reverses policy to mandate individual arbitration for employment disputes, limiting legal recourse for workers. Move follows prior class-action waivers.
Matthews International appoints Michael Whitehead as new CEO
Pittsburgh-based Matthews International names Michael Whitehead as CEO, replacing interim leader following recent board changes.
Apollomics secures $10 million in private placement funding
Biotech firm Apollomics raises fresh capital via private placement to advance pipeline development and clinical trials. Proceeds to support late-stage oncology programs.
Realty Income to raise $750 mln via convertible notes
REIT plans offering of convertible senior notes due 2029, proceeds to fund general corporate purposes including potential acquisitions.
Three Innoviva therapies named Prix Galien finalists
Innoviva's respiratory treatments advance in prestigious biopharma awards, highlighting pipeline progress.
Triveni Turbine posts Q1 FY27 revenue growth, margin pressure
India’s wind turbine manufacturer reports 12% year-on-year revenue increase but warns of margin compression amid rising input costs.
Uniper targets EBITDA doubling by H1 2026 with data center push
German utility Uniper outlines plans to double EBITDA by the first half of 2026, driven by expansion in data center energy supply and infrastructure.
SINTX forecasts Q3 revenue between $900,000 and $1.1 million
Biotech firm SINTX Technologies provides preliminary Q3 revenue guidance, signaling a sequential decline from prior quarters.
CNB Financial declares $0.19 quarterly dividend
The Pennsylvania-based bank joins peers in maintaining shareholder returns amid stable earnings and capital position.
Trulieve completes move from Canada to Delaware corporate domicile
U.S. cannabis firm Trulieve finalizes redomiciliation to Delaware after shareholder approval, shifting legal base from Canada to align with domestic operations.
Insteel Industries declares $0.03 quarterly dividend
Steel manufacturer Insteel Industries sets quarterly cash dividend at $0.03 per share, payable to shareholders on record as of April 17.
NiSource raises quarterly dividend to $0.30 per share
Utility company declares a 3.4% increase in its quarterly dividend, marking the latest in a series of payout hikes.
Prudential sets $1.40 quarterly dividend per share
Insurer declares dividend as part of regular quarterly payout cycle, aligning with prior distributions.
Energy Vault shares jump 11% after Q2 beat, raised guidance
Energy storage firm Energy Vault reports second-quarter revenue and earnings above estimates, lifts full-year outlook as demand for grid-scale solutions grows.
VSE Corp shares hit record $241.27 as defense demand rises
Defense logistics provider VSE Corp closes at an all-time high, extending gains amid sustained government contract awards.
Mechanics Bancorp shares reach 52-week high at $17.20
Stock climbs to its highest level since mid-2023 as regional lender extends recent gains.
Seneca Foods shares hit record $185.06 on strong earnings
Shares of Seneca Foods Corp B reached an all-time high after the company reported better-than-expected quarterly results and raised its full-year guidance.
Wave Life Sciences shares hit 52-week low of $5.01
The biotech firm's stock fell to its lowest level in a year, reflecting broader pressures in the sector amid weak investor sentiment.
Crinetics Pharmaceuticals shares hit record $84.35
Stock reaches all-time high amid strong investor interest in biotech sector. No company commentary provided.
Aurora Cannabis rejects Curaleaf’s takeover bid
Aurora Cannabis declines Curaleaf’s unsolicited $1.1 billion proposal, citing strategic misalignment and shareholder value concerns.